Kaul CL - Search Results

1

Co-treatment with grapefruit juice inhibits while chronic administration activates intestinal P-glycoprotein-mediated drug efflux.

Panchagnula R, Bansal T, Varma MV, Kaul CL. Panchagnula R, et al. Among authors: kaul cl. Pharmazie. 2005 Dec;60(12):922-7. Pharmazie. 2005. PMID: 16398269

2

Reversed-phase liquid chromatography with ultraviolet detection for simultaneous quantitation of indinavir and propranolol from ex-vivo rat intestinal permeability studies.

Panchagnula R, Bansal T, Varma MV, Kaul CL. Panchagnula R, et al. Among authors: kaul cl. J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Jul 5;806(2):277-82. doi: 10.1016/j.jchromb.2004.04.009. J Chromatogr B Analyt Technol Biomed Life Sci. 2004. PMID: 15171939

3

Bioequivalence of isoniazid in a two drug fixed dose combination and in a single drug dosage form.

Agrawal S, Kaul CL, Panchagnula R. Agrawal S, et al. Among authors: kaul cl. Pharmazie. 2001 Aug;56(8):636-9. Pharmazie. 2001. PMID: 11534341 Clinical Trial.

4

Fixed dose combinations for tuberculosis: Lessons learned from clinical, formulation and regulatory perspective.

Panchagnula R, Agrawal S, Ashokraj Y, Varma M, Sateesh K, Bhardwaj V, Bedi S, Gulati I, Parmar J, Kaul CL, Blomberg B, Fourie B, Roscigno G, Wire R, Laing R, Evans P, Moore T. Panchagnula R, et al. Among authors: kaul cl. Methods Find Exp Clin Pharmacol. 2004 Nov;26(9):703-21. doi: 10.1358/mf.2004.26.9.872568. Methods Find Exp Clin Pharmacol. 2004. PMID: 15632956 Free article. Review.

5

In vitro evaluation of food effect on the bioavailability of rifampicin from antituberculosis fixed dose combination formulations.

Panchagnula R, Rungta S, Sancheti P, Agrawal S, Kaul CL. Panchagnula R, et al. Among authors: kaul cl. Farmaco. 2003 Nov;58(11):1099-103. doi: 10.1016/S0014-827X(03)00161-7. Farmaco. 2003. PMID: 14572860

6

Pharmacokinetic evaluation of an azithromycin controlled release dosage form in healthy human volunteers: a single dose study.

Gandhi R, Kaul CL, Panchagnula R. Gandhi R, et al. Among authors: kaul cl. Int J Pharm. 2004 Feb 11;270(1-2):1-8. doi: 10.1016/j.ijpharm.2003.09.046. Int J Pharm. 2004. PMID: 14726116 Clinical Trial.

7

Bioequivalence trials of rifampicin containing formulations: extrinsic and intrinsic factors in the absorption of rifampicin.

Agrawal S, Singh I, Kaur KJ, Bhade S, Kaul CL, Panchagnula R. Agrawal S, et al. Among authors: kaul cl. Pharmacol Res. 2004 Sep;50(3):317-27. doi: 10.1016/j.phrs.2004.01.009. Pharmacol Res. 2004. PMID: 15225676

8

The WHO simplified study protocol in practice: investigation of combined formulations supplied by the WHO.

Panchagnula R, Kaur KJ, Singh I, Kaul CL. Panchagnula R, et al. Among authors: kaul cl. Int J Tuberc Lung Dis. 1999 Nov;3(11 Suppl 3):S336-42; discussion S351-2. Int J Tuberc Lung Dis. 1999. PMID: 10593714 Clinical Trial.

9

Bioequivalence study of rifampicin in fixed-dose combination of rifampicin and isoniazid vs. separate formulations.

Panchagnula R, Singh I, Kaur KJ, Kaul CL. Panchagnula R, et al. Among authors: kaul cl. Methods Find Exp Clin Pharmacol. 1999 Nov;21(9):625-8. Methods Find Exp Clin Pharmacol. 1999. PMID: 10669909 Clinical Trial.

10

Bioequivalence of rifampicin when administered as a fixed-dose combined formulation of four drugs versus separate formulations.

Panchagnula R, Kaur KJ, Singh I, Kaul CL. Panchagnula R, et al. Among authors: kaul cl. Methods Find Exp Clin Pharmacol. 2000 Nov;22(9):689-94. doi: 10.1358/mf.2000.22.9.802285. Methods Find Exp Clin Pharmacol. 2000. PMID: 11294011 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

113 results

Search Page

Filters